189 related articles for article (PubMed ID: 34394706)
1. Bioinformatic Analysis of Prognostic and Immune-Related Genes in Pancreatic Cancer.
Li Z; Hu C; Yang Z; Yang M; Fang J; Zhou X
Comput Math Methods Med; 2021; 2021():5549298. PubMed ID: 34394706
[TBL] [Abstract][Full Text] [Related]
2. Identifying and Validating an Acidosis-Related Signature Associated with Prognosis and Tumor Immune Infiltration Characteristics in Pancreatic Carcinoma.
Tang P; Qu W; Wu D; Chen S; Liu M; Chen W; Ai Q; Tang H; Zhou H
J Immunol Res; 2021; 2021():3821055. PubMed ID: 34993253
[TBL] [Abstract][Full Text] [Related]
3. Using ESTIMATE algorithm to establish an 8-mRNA signature prognosis prediction system and identify immunocyte infiltration-related genes in Pancreatic adenocarcinoma.
Meng Z; Ren D; Zhang K; Zhao J; Jin X; Wu H
Aging (Albany NY); 2020 Mar; 12(6):5048-5070. PubMed ID: 32181755
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of MYEOV predicting poor prognosis in patients with pancreatic ductal adenocarcinoma.
Tang R; Ji J; Ding J; Huang J; Gong B; Zhang X; Li F
Cell Cycle; 2020 Jul; 19(13):1602-1610. PubMed ID: 32420813
[TBL] [Abstract][Full Text] [Related]
5. Identification and validation of an immune prognostic signature in colorectal cancer.
Li M; Wang H; Li W; Peng Y; Xu F; Shang J; Dong S; Bu L; Wang H; Wei W; Hu Q; Liu L; Zhao Q
Int Immunopharmacol; 2020 Nov; 88():106868. PubMed ID: 32771948
[TBL] [Abstract][Full Text] [Related]
6. S100A2 Is a Prognostic Biomarker Involved in Immune Infiltration and Predict Immunotherapy Response in Pancreatic Cancer.
Chen Y; Wang C; Song J; Xu R; Ruze R; Zhao Y
Front Immunol; 2021; 12():758004. PubMed ID: 34887861
[TBL] [Abstract][Full Text] [Related]
7. Bioinformatics profiling utilized a nine immune-related long noncoding RNA signature as a prognostic target for pancreatic cancer.
Wei C; Liang Q; Li X; Li H; Liu Y; Huang X; Chen X; Guo Y; Li J
J Cell Biochem; 2019 Sep; 120(9):14916-14927. PubMed ID: 31016791
[TBL] [Abstract][Full Text] [Related]
8. Establishment and Investigation of a Multiple Gene Expression Signature to Predict Long-Term Survival in Pancreatic Cancer.
Zhang Z; Gu J; Yin M; Wang D; Ma C; Du J; Lin Z; Hu S; Wang X; Li Y; Tan G; Luo H; Wei G
Biomed Res Int; 2020; 2020():1570862. PubMed ID: 33015155
[TBL] [Abstract][Full Text] [Related]
9. Exploring the significance of novel immune-related gene signatures in the prognosis and immune features of pancreatic adenocarcinoma.
Chen B; Hu C; Jiang L; Xiang Z; Zuo Z; Lin Y; Liu C
Int Immunopharmacol; 2021 Mar; 92():107359. PubMed ID: 33465729
[TBL] [Abstract][Full Text] [Related]
10. Characterization of the prognostic and oncologic values of ITGB superfamily members in pancreatic cancer.
Zhuang H; Zhou Z; Ma Z; Li Z; Liu C; Huang S; Zhang C; Hou B
J Cell Mol Med; 2020 Nov; 24(22):13481-13493. PubMed ID: 33073486
[TBL] [Abstract][Full Text] [Related]
11. Novel three‑lncRNA signature predicts survival in patients with pancreatic cancer.
Wu B; Wang K; Fei J; Bao Y; Wang X; Song Z; Chen F; Gao J; Zhong Z
Oncol Rep; 2018 Dec; 40(6):3427-3437. PubMed ID: 30542694
[TBL] [Abstract][Full Text] [Related]
12. MYEOV overexpression induced by demethylation of its promoter contributes to pancreatic cancer progression via activation of the folate cycle/c-Myc/mTORC1 pathway.
Tange S; Hirano T; Idogawa M; Hirata E; Imoto I; Tokino T
BMC Cancer; 2023 Jan; 23(1):85. PubMed ID: 36698109
[TBL] [Abstract][Full Text] [Related]
13. Integrated Analysis of Multi-Omics Data to Identify Prognostic Genes for Pancreatic Cancer.
Jiang F; Huang X; Zhang F; Pan J; Wang J; Hu L; Chen J; Wang Y
DNA Cell Biol; 2022 Mar; 41(3):305-318. PubMed ID: 35104421
[TBL] [Abstract][Full Text] [Related]
14. Identification of the immune cell infiltration landscape in pancreatic cancer to assist immunotherapy.
Wang Z; Zou W; Wang F; Zhang G; Chen K; Hu M; Liu R
Future Oncol; 2021 Nov; 17(31):4131-4143. PubMed ID: 34346253
[TBL] [Abstract][Full Text] [Related]
15. Identification of Five Immune-Related lncRNAs Predicting Survival and Tumor Microenvironment Characteristics in Breast Cancer.
Xiao R; Yang M; Tan Y; Ding R; Li D
Comput Math Methods Med; 2021; 2021():6676692. PubMed ID: 33727952
[TBL] [Abstract][Full Text] [Related]
16. Identification of candidate diagnostic and prognostic biomarkers for pancreatic carcinoma.
Cheng Y; Wang K; Geng L; Sun J; Xu W; Liu D; Gong S; Zhu Y
EBioMedicine; 2019 Feb; 40():382-393. PubMed ID: 30639415
[TBL] [Abstract][Full Text] [Related]
17. Identification of prognostic genes in uveal melanoma microenvironment.
Luo H; Ma C
PLoS One; 2020; 15(11):e0242263. PubMed ID: 33196683
[TBL] [Abstract][Full Text] [Related]
18. Predicting the clinical outcome of melanoma using an immune-related gene pairs signature.
Meng L; He X; Zhang X; Zhang X; Wei Y; Wu B; Li W; Li J; Xiao Y
PLoS One; 2020; 15(10):e0240331. PubMed ID: 33031392
[TBL] [Abstract][Full Text] [Related]
19. UGT1A Gene Family Members Serve as Potential Targets and Prognostic Biomarkers for Pancreatic Cancer.
Feng L; Wang Y; Qin J; Fu Y; Guo Z; Zhang J; He G; Jiang Z; Xu X; Zhou C; Gao Y
Biomed Res Int; 2021; 2021():6673125. PubMed ID: 34595239
[TBL] [Abstract][Full Text] [Related]
20. An eight-miRNA signature expression-based risk scoring system for prediction of survival in pancreatic adenocarcinoma.
Dou D; Yang S; Lin Y; Zhang J
Cancer Biomark; 2018; 23(1):79-93. PubMed ID: 29991127
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]